Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial
Xiaobo Cai, Yin Qu, Wen Xie, Yanbin Wang, Mengyu Zhao, Ling Zhang, Ying Luo, Ping Yin, Jun Cheng, Lungen Lu
[ Html ]
[ PDF ] 361-366
doi:10.14218/JCTH.2024.00472
Inhibition of Cyclooxygenase-2 Upregulates the Nuclear Factor Erythroid 2-related Factor 2 Signaling Pathway to Mitigate Hepatocyte Ferroptosis in Chronic Liver Injury
Zhu Yang, Yang Tai, Tian Lan, Chong Zhao, Jin-Hang Gao, Cheng-Wei Tang, Huan Tong
[ Html ]
[ PDF ] 409-417
doi:10.14218/JCTH.2024.00440
Prevalence of Hepatitis B Core Antibody in Intravenous Immunoglobulin Products by Chemiluminescent Microparticle Immunoassay
Laura Victoria, Anu S. Maharjan, Julia Kostka, Raphael Assenso-Bediako, Wesley Merkert, Lisa Chirch, Kevin Dieckhaus
[ Html ]
[ PDF ] 358-360
doi:10.14218/JCTH.2024.00464
Mitochondrial Membrane Potential of CD8+ T Cells Predicts Bacterial Infection and Rapid Development of Acute-on-chronic Liver Failure in Cirrhotic Patients
Xixuan Wang, Shuling Chen, Jing Fan, Yuxiang Gong, Hongli Liu, Lili Wang, Xiaoning Feng, Hui Zhou, Wenquan Zeng, Changhua Yi, Caiyun Zhang, Qingfang Xiong, Hao Ren, Yongfeng Yang
[ Html ]
[ PDF ] 395-408
doi:10.14218/JCTH.2024.00452
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection
Xieer Liang, Qiaoqiao Chen, Hong Tang, Yujuan Guan, Minfeng Liang, Peng Hu, Wen Xie, Huiying Rao, Junqi Niu, Liang Chen, Li Yan, Xiaowei Chen, Xiaohe Li, Yulin Zhao, Oliver Lenz, Michael Biermer, Jinlin Hou
[ Html ]
[ PDF ] 278-283
doi:10.14218/JCTH.2024.00313
Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review
Lynette M. Sequeira, N. Begum Ozturk, Leandro Sierra, Merve Gurakar, Merih Deniz Toruner, Melanie Zheng, Cem Simsek, Ahmet Gurakar, Amy K. Kim
[ Html ]
[ PDF ] 327-338
doi:10.14218/JCTH.2024.00432
Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson’s Disease Hepatic Type
Yu-Jia Lu, Chuan-Su Yuan, Yue-Yang Ma, Ke-Ying Ou, Du-Xian Liu, Bin Liu, Yong-Feng Yang, Qing-Fang Xiong
[ Html ]
[ PDF ] 306-314
doi:10.14218/JCTH.2024.00453
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024)
Xiaoyuan Xu, Huiguo Ding, Wengang Li, Ying Han, Yujuan Guan, Jinghang Xu, Yifan Han, Jidong Jia, Lai Wei, Zhongping Duan, Yuemin Nan, Hui Zhuang, Chinese Society of Hepatology, Chinese Medical Association
[ Html ]
[ PDF ] 253-267
doi:10.14218/JCTH.2024.00484
PCSK9 and APOA4: The Dynamic Duo in TMAO-induced Cholesterol Metabolism and Cholelithiasis
Chao Shi, Jingjing Yu, Ziang Meng, Dongxu Lu, Haoran Ding, Haijun Sun, Guangxin Shi, Dongbo Xue, Xianzhi Meng
[ Html ]
[ PDF ] 295-305
doi:10.14218/JCTH.2024.00403
GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway
Yani Wu, Yingnan Yang, Youju Zhang, Qiuran Xu, Dongsheng Huang, Kangsheng Tu
[ Html ]
[ PDF ] 374-384
doi:10.14218/JCTH.2024.00386
Beyond the Cure: Navigating Hepatocellular Risk and Surveillance after Hepatitis C Eradication in the Direct-acting Antiviral Era
Chencheng Xie, Ashwani K. Singal
[ Html ]
[ PDF ] 418-424
doi:10.14218/JCTH.2024.00499
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis
Chi Zhang, Xuanran Yang, Yi Xue, Huan Li, Chuanfei Zeng, Mingkai Chen
[ Html ]
[ PDF ] 233-252
doi:10.14218/JCTH.2024.00348